Antibody-mediated Rejection After Lung Transplantation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-31
Clinical Trial Update: A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation [Phase 1]
Phase 1 study investigating siltuximab for antibody-mediated rejection after lung transplantation is currently recruiting.